Champions Oncology
Quarterly Financials
| Values in thousands | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
|---|---|---|---|---|
Revenue | $17,039 | $13,489 | $14,061 | $14,001 |
Gross Profit | 10,422 | 6,417 | 6,989 | 6,751 |
EBITDA | 4,897 | 1,131 | 1,778 | 621 |
EBIT | 4,499 | 732 | 1,329 | 164 |
Net Income | 4,495 | 728 | 1,313 | -109 |
Net Change In Cash | 17,039 | 13,489 | 14,061 | 14,001 |
Free Cash Flow | 448 | -377 | 311 | -1,705 |
Cash | 3,202 | 2,754 | 2,892 | 2,618 |
Basic Shares | 14,364 | 14,016 | 14,042 | 13,593 |
Annual Financials
| Values in thousands | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|
Revenue | $50,155 | $53,870 | $49,109 | $41,040 |
Gross Profit | 20,754 | 24,338 | 25,477 | 19,566 |
EBITDA | -5,054 | -2,069 | 2,234 | 366 |
EBIT | -6,921 | -5,267 | -179 | -1,216 |
Net Income | -7,276 | -5,335 | 548 | 362 |
Net Change In Cash | 50,155 | 53,870 | 49,109 | 41,040 |
Cost of Revenue | 1,111 | 4,320 | -3,655 | |
Free Cash Flow | -6,973 | 1,083 | 4,113 | -4,962 |
Cash | 2,618 | 10,118 | 9,007 | 4,687 |
Basic Shares | 13,547 | 13,541 | 14,159 | 14,573 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-01-31 | $0.33 |
2024-10-31 | $0.05 |
2024-07-31 | $0.11 |
2024-04-30 | $0.01 |
